Institutional Ownership
Acurx Pharmaceuticals Inc
CUSIP 00510M203COM NEWACXPQ1 2026
Institutional Holders
20
13F filers
Shares Held
135.9K
Aggregate institutional
Institutional Value
$429.7K
Q1 2026
Net New Holders
+3
6 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions6
Increased3
Decreased4
Sold out3
Institutional Holders
20 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Jane Street Group, LLC | 54.6K | $202.7K | +43.9K | Added |
| 2 | Geode Capital Management, LLC | 24.8K | $92.1K | +12.4K | Added |
| 3 | Prospect Financial Services LLC | 13.8K | $51.1K | −6.0K | Reduced |
| 4 | Morgan Stanley | 6.5K | $24.1K | 0 | Held |
| 5 | Ubs Group AG | 6.3K | $23.4K | +6.1K | Added |
| 6 | Wells Fargo & Company/Mn | 2.3K | $8.5K | 0 | Held |
| 7 | Westside Investment Management, Inc. | 1.6K | $6.1K | +1.6K | New |
| 8 | Nbc Securities, Inc. | 1.5K | $5.6K | 0 | Held |
| 9 | Western Wealth Management, LLC | 1.3K | $4.9K | +1.3K | New |
| 10 | Tower Research Capital LLC (Trc) | 1.0K | $3.8K | −1.9K | Reduced |
10 more institutional holders on Premium
See every fund holding Acurx Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders